Multinational clinical studies are increasing, KFDA says

The number of multinational clinical trials conducted by multinational pharmaceutical companies in Korea, is expected to reach 150 this year, pointing to the rapid development of the local clinical infrastructure sector, according to the Korea Food and Drug Administration.

The nation's drug watchdog said it approved more than 90 trials for multinational drug makers last year, up 39 percent f...